Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 31;7(7):CD005406.
doi: 10.1002/14651858.CD005406.pub5.

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease

Uduak Okomo  1 , Martin M Meremikwu
Affiliations

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease

Uduak Okomo et al. Cochrane Database Syst Rev. .

Abstract

Background: Treating vaso-occlusive painful crises in people with sickle cell disease is complex and requires multiple interventions. Extra fluids are routinely given as adjunct treatment, regardless of the individual's state of hydration with the aim of slowing or stopping the sickling process and thereby alleviating pain. This is an update of a previously published Cochrane Review.

Objectives: To determine the optimal route, quantity and type of fluid replacement for people with sickle cell disease with acute painful crises.

Search methods: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which comprises of references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings.We also conducted searches of Embase (November 2007), LILACS, www.ClinicalTrials.gov (05 January 2010), and the WHO ICTRP (30 June 2017).Date of most recent search of the Group's Haemoglobinopathies Trials Register: 16 February 2017.

Selection criteria: Randomised and quasi-randomised controlled trials that compared the administration of supplemental fluids adjunctive to analgesics by any route in people with any type of sickle cell disease during an acute painful episode, under medical supervision (inpatient, day care or community).

Data collection and analysis: No relevant trials have yet been identified.

Main results: Sixteen trials were identified by the searches, all of which were not eligible for inclusion in the review.

Authors' conclusions: Treating vaso-occlusive crises is complex and requires multiple interventions. Extra fluids, generally oral or intravenous, are routinely administered during acute painful episodes to people with sickle cell disease regardless of the individual's state of hydration. Reports of their use during these acute painful episodes do not state the efficacy of any single route, type or quantity of fluid compared to another. However, there are no randomised controlled trials that have assessed the safety and efficacy of different routes, types or quantities of fluid. This systematic review identifies the need for a multicentre randomised controlled trial assessing the efficacy and possible adverse effects of different routes, types and quantities of fluid administered to people with sickle cell disease during acute painful episodes.

PubMed Disclaimer

Conflict of interest statement

Both authors: none known.

Update of

References

References to studies excluded from this review

Alvim 2005 {published data only}
    1. Alvim RC, Viana MB, Pires MAS, Franklin HMOH, Paula MJ, Brito AC, et al. Inefficacy of piracetam in the prevention of painful crisis in children and adolescents with sickle cell disease. Acta Haematologica 2005;113(4):228-33. - PubMed
Beiter Jr 2001 {published data only}
    1. Beiter JL Jr, Simon HK, Chambliss CR, Adamkiewicz T, Sullivan K. Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness. Archives of Paediatrics and Adolescent Medicine 2001;155(4):496-500. [ISSN: 1072-4710] - PubMed
Charache 1981 {published data only}
    1. Charache S, Walker WG. Failure of desmopressin to lower serum sodium or prevent crisis in patients with sickle cell anemia. Blood 1981;58(5):892-6. - PubMed
Charache 1983 {published data only}
    1. Charache S, Moyer MA, Walker WG. Treatment of acute sickle cell crises with a vasopressin analogue. American Journal of Hematology 1983;15(4):315-9. - PubMed
de Araujo 1994 {published data only}
    1. Araujo JT, Comerlatti LK, Araujo RA, Bodemeier L. Treatment of sickle cell anemia crisis with dipyrone, hydrocortisone and fluid therapy. Revista do Hospital das Clinicas 1994;49(1):13-6. - PubMed
Gonzalez 1988 {published data only}
    1. Gonzalez ER, Ornato JP, Ware D, Bull D, Evens RP. Comparison of intramuscular analgesic activity of butorphanol and morphine in patients with sickle cell disease. Annals of Emergency Medicine 1988;17(8):788-91. - PubMed
Gonzalez 1991 {published data only}
    1. Gonzalez ER, Bahal N, Hansen LA, Ware D, Bull DS, Ornato JP, et al. Intermittent injection versus patient-controlled analgesia for sickle cell crisis pain: Comparison in patients in the emergency department. Archives of Internal Medicine 1991;151(7):1373-8. - PubMed
Guy 1971 {published data only}
    1. Guy R, Rothernberg SP. Treatment of sickle cell crisis with hypotonic saline. Clinical Research 1971;21:420.
Guy 1973 {published data only}
    1. Guy RB, Gavrilis PK, Rothenberg SP. In vitro and in vivo effect of hypotonic saline on the sickling phenomenon. American Journal of The Medical Sciences 1973;266(4):267-77. - PubMed
Hardwick Jr 1999 {published data only}
    1. Hardwick WE Jr, Givens TG, Monroe KW, King WD, Lawley D. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis. Pediatric Emergency Care 1999;15(3):179-82. - PubMed
Hatch 1965 {published data only}
    1. Hatch FE, Diggs LW. Fluid balance in sickle cell disease. Archives of Internal Medicine 1965;116:10-7. - PubMed
Kalinyak 2005 {published data only}
    1. Kalinyak K, Terry AL, Hodgson M. Dipyridamole/Magnesium to improve sickle cell hydration. http://www.clinicaltrials.gov (accessed 15 February 2007). [NCT00276146]
Nalbandian 1971 {published data only}
    1. Nalbandian RM, Schultz G, Lusher JM, Anderson JW, Henry RL. Sickle cell crisis terminated by intravenous urea in sugar solutions - a preliminary report. American Journal of the Medical Sciences 1971;261(6):309-24. - PubMed
Orringer 2001 {published data only}
    1. Orringer EP, Casella JF, Ataga KI, Koshy M, Adams-Graves P, Lutchman-Jones L, et al. Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial. JAMA 2001;286(17):2099-106. - PubMed
Oski 1965 {published data only}
    1. Oski FA, Viner ED, Perugganan H, McElfresh AE. Low molecular weight dextran in sickle cell crisis. JAMA 1965;191:43. - PubMed
Rhodes 1974 {published data only}
    1. Rhodes RS, Revo L, Hara S. Therapy for sickle cell vaso-occlusive crises. Controlled clinical trials and cooperative study of intravenously administered alkali. Journal of The American Medical Association 1974;228(9):1129-31. - PubMed

Additional references

Adam 1996
    1. Adam S. Caring for the pregnant woman with sickle cell crisis. Professional Care of Mother and Child 1996;6(2):34-6. - PubMed
Adekile 1999
    1. Adekile AD. Haemoglobinopathies. In: Azubike JC, Nkanginieme KEO, editors(s). Paediatrics and Child Health in a Tropical Region. Owerri: African Educational Services, 1999:200.
Allon 1990
    1. Allon M. Renal abnormalities in sickle cell disease. Archives of Internal Medicine 1990;150(3):501-4. - PubMed
Ballas 2005
    1. Ballas SK. Pain management of sickle cell disease. Haematology/Oncology Clinics of North America 2005;19(5):785-802. - PubMed
Ballas 2007
    1. Ballas SK. Current Issues in Sickle Cell Pain and Its Management. Hematology 2007;1:97-105. - PubMed
Brugnara 1995
    1. Brugnara C. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease. Current Opinion in Hematology 1995;2(2):132-8. - PubMed
Charache 1995
    1. Charache S, Terrin M, Moore R, Dover G, Barton F, Eckert S, et al. Effect of Hydroxyurea on the frequency of painful crisis in sickle cell anaemia. New England Journal of Medicine 1995;332(20):1317-22. - PubMed
De Ceulaer 1982
    1. De Ceulaer K, Gruber C, Hayes R, Serjeant GR. Medroxyprogesterone acetate and homozygous sickle-cell disease. Lancet 1982;2(8292):229-31. - PubMed
Gaston 1986
    1. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, et al. Prophylaxis with oral penicillin in children with sickle cell anaemia. New England Journal of Medicine 1986;314(25):1593-9. - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Keitel 1956
    1. Keitel HG, Thompson D, Itano HA. Hyposthenuria in sickle cell anemia: a reversible renal defect. Journal of Clinical Investigation 1956;35(9):998-1007. - PMC - PubMed
Kontessis 1992
    1. Kontessis P, Mayopoulou-Symvoulidis D, Symvoulidis A, Kontopoulou-Griva I. Renal involvement in sickle cell-thalassaemia. Nephron 1992;61(1):10-5. - PubMed
Lane 2001a
    1. Lane PA, Nuss R, Ambruso D. Hematologic disorders. In: Hay WW, Hayward AR, Levin MJ, Sondheimer JM, editors(s). Current Pediatric Diagnosis and Treatment. 15th edition. New York: McGraw-Hill Companies Inc, 2001:756-9.
Lane 2001b
    1. Lane PA, Buchanan GR, Hutter JJ, Austin RF, Britton HA, Rogers ZR, et al. Inpatient management of vaso-occlusive pain in child with sickle cell disease. Sickle cell disease in children and adolescents: Diagnosis, guidelines for comprehensive care, and care paths and protocols for management of acute and chronic complications; http://www.scinfo.org/protchildindex.htm 2001:17.
Martí‐Carvajal 2009
    1. Martí-Carvajal AJ, Peña-Martí GE, Comunián-Carrasco G, Martí-Peña AJ. Interventions for treating painful sickle cell crisis during pregnancy. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No: CD006786. [DOI: 10.1002/14651858.CD006786.pub2] - DOI - PMC - PubMed
Platt 1991
    1. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease. Rates and risk factors. New England Journal of Medicine 1991;325(1):11-6. - PubMed
Rosa 1980
    1. Rosa RM, Bierer BE, Thomas R, Stoff JS, Kruskall M, Robinson S, et al. A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis. New England Journal of Medicine 1980;303(20):1138-43. - PubMed
Saborio 1999
    1. Saborio P, Scheinman JI. Sickle Cell Nephropathy. Journal of the American Society of Nephrology 1999;10(1):187-92. - PubMed
SCIC 2005
    1. Sickle Cell Information Center. Sickle cell information - Clinician Summary. http://www.scinfo.org/prod05.htm (accessed January 2005).
Serjeant 1992
    1. Serjeant GR. Sickle Cell Disease. 2nd edition. New York: Oxford Medical Publications, 1992.
Statius van Eps 1967
    1. Statius van Eps LW, Schouten H, La Porte-Wijsman LW, Struyker Boudier AM. The influence of red blood cell transfusions on the hyposthenuria and renal hemodynamics of sickle cell anemia. International Journal of Clinical Chemistry 1967;17(3):449-61. - PubMed
Steinberg 1999
    1. Steinberg MH. Management of sickle cell disease. New England Journal of Medicine 1999;340(13):1021-30. - PubMed
Steinberg 2006
    1. Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends in Pharmacological Sciences 2006;27(4):204-10. - PubMed

References to other published versions of this review

Okomo 2007
    1. Okomo U, Meremikwu MM. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No: CD005406. [DOI: 10.1002/14651858.CD005406.pub2] - DOI - PubMed
Okomo 2012
    1. Okomo U, Meremikwu MM. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database of Systematic Reviews 2012, Issue 6. Art. No: CD005406. [DOI: 10.1002/14651858.CD005406.pub3] - DOI - PubMed
Okomo 2015
    1. Okomo U, Meremikwu MM. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No: CD005406. [DOI: 10.1002/14651858.CD005406.pub4] - DOI - PubMed

Publication types

LinkOut - more resources